0.312
price down icon1.88%   -0.00599
after-market Handel nachbörslich: .31 -0.002 -0.64%
loading
Schlusskurs vom Vortag:
$0.318
Offen:
$0.315
24-Stunden-Volumen:
131.44K
Relative Volume:
0.04
Marktkapitalisierung:
$3.52M
Einnahmen:
$1.75M
Nettoeinkommen (Verlust:
$-5.68M
KGV:
-0.064
EPS:
-4.8726
Netto-Cashflow:
-
1W Leistung:
-0.57%
1M Leistung:
+0.61%
6M Leistung:
+30.54%
1J Leistung:
-66.95%
1-Tages-Spanne:
Value
$0.3086
$0.3283
1-Wochen-Bereich:
Value
$0.30
$0.33
52-Wochen-Spanne:
Value
$0.197
$1.79

Scisparc Ltd Stock (SPRC) Company Profile

Name
Firmenname
Scisparc Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
2
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
SPRC's Discussions on Twitter

Vergleichen Sie SPRC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SPRC
Scisparc Ltd
0.312 3.52M 1.75M -5.68M 0 -4.8726
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Scisparc Ltd Aktie (SPRC) Neueste Nachrichten

pulisher
Jun 03, 2025

Therapix Biosciences Ltd. Announces Executive Changes - marketscreener.com

Jun 03, 2025
pulisher
May 28, 2025

SciSparc announces publication of Japanese patent application - MSN

May 28, 2025
pulisher
May 27, 2025

SciSparc Unveils Japanese Patent for Novel Pain Relief Combination - TipRanks

May 27, 2025
pulisher
May 27, 2025

SciSparc secures Japanese patent for pain relief combo By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

SciSparc Ltd. Announces Publication of Japanese Patent Application - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

SciSparc secures Japanese patent for pain relief combo - Investing.com

May 27, 2025
pulisher
May 27, 2025

SciSparc Ltd. Announces Publication of Novel Japanese Patent for Enhanced Pain Management Therapy Combining Paracetamol and PEA - Nasdaq

May 27, 2025
pulisher
May 27, 2025

SciSparc Announces Publication of Japanese Patent Application - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

SciSparc's New Pain Relief Patent Could Make Paracetamol Safer for Millions - Stock Titan

May 27, 2025
pulisher
May 21, 2025

SciSparc sets annual shareholder meeting for June 25 By Investing.com - Investing.com Nigeria

May 21, 2025
pulisher
May 21, 2025

SciSparc sets annual shareholder meeting for June 25 - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

SciSparc Ltd. Announces Annual General Meeting for June 2025 - TipRanks

May 21, 2025
pulisher
May 13, 2025

SciSparc and Clearmind Secure European Patent for Cocaine Addiction Therapy - TipRanks

May 13, 2025
pulisher
May 12, 2025

SciSparc Ltd. Announces European Patent Application for Cocaine Addiction Treatment in Collaboration with Clearmind Medicine Inc. - Nasdaq

May 12, 2025
pulisher
May 12, 2025

SciSparc-Clearmind Collaboration Leads to Publication of - GlobeNewswire

May 12, 2025
pulisher
May 12, 2025

SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction - Stock Titan

May 12, 2025
pulisher
May 03, 2025

Aegis Capital Corp. acted as Exclusive Placement Agent on a $5.0 Million Private Placement for SciSparc Ltd. (NASDAQ: SPRC) - The Globe and Mail

May 03, 2025
pulisher
May 02, 2025

SciSparc Ltd: Weathering Stock Market Storms with 3.17M Market Cap - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

A review of SPRC’s current quarter earnings predictions - uspostnews.com

May 02, 2025
pulisher
Apr 30, 2025

What's Going On With jeffs' Brands Today? - Benzinga

Apr 30, 2025
pulisher
Apr 30, 2025

Jeffs' Brands to Sell Smart Repair Pro Unit, SciSparc Nutraceuticals Stake to Plantify Foods; Shares Jump - marketscreener.com

Apr 30, 2025
pulisher
Apr 25, 2025

SciSparc and Clearmind file patent for eating disorder treatment - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc and Clearmind file patent for eating disorder treatment By Investing.com - Investing.com India

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc announces collaboration with Clearmind Medicine - TipRanks

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc and Clearmind File Patent for Eating Disorder Treatment - TipRanks

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders - The Manila Times

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc-Clearmind Collaboration Leads to Filing of - GlobeNewswire

Apr 25, 2025
pulisher
Apr 25, 2025

Novel Eating Disorder Treatment Patent Filed for 70M Patient Market | SPRC Stock News - Stock Titan

Apr 25, 2025
pulisher
Apr 25, 2025

3 Reasons OMI is Risky and 1 Stock to Buy Instead - The Globe and Mail

Apr 25, 2025
pulisher
Apr 18, 2025

Thinking Of Selling SciSparc Ltd (NASDAQ: SPRC) Stock? Check This Out First - Stocksregister

Apr 18, 2025
pulisher
Apr 17, 2025

SciSparc (NASDAQ:SPRC) Shares Down 6% – Here’s Why - Defense World

Apr 17, 2025
pulisher
Apr 01, 2025

SciSparc Extends Deadline for Miza III Ventures Deal - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

SciSparc Ltd. Extends Merger Agreement with AutoMax Motors - TipRanks

Apr 01, 2025
pulisher
Mar 27, 2025

SciSparc Ltd. (NASDAQ:SPRC) Short Interest Up 1,435.0% in March - Defense World

Mar 27, 2025
pulisher
Mar 25, 2025

SciSparc announces resale of 61.21M shares by selling shareholders; shares down - MSN

Mar 25, 2025
pulisher
Mar 21, 2025

SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement - Louisiana First News

Mar 21, 2025
pulisher
Mar 11, 2025

SciSparc and Clearmind Advance Cocaine Addiction Treatment with South Korean Patent Application - TipRanks

Mar 11, 2025
pulisher
Mar 10, 2025

Is the SciSparc Ltd (NASDAQ:SPRC) stock an investment opportunity? - US Post News

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc Shares Are Soaring Monday: What's Going On? - Benzinga

Mar 10, 2025
pulisher
Mar 10, 2025

Scisparc, Clearmind apply for patent in South Korea for its co-developed treatment to overcome cocaine addiction - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc announces publication of patent via Clearmind collaboration - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea - The Manila Times

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc Ltd. and Clearmind Medicine Inc. Announce Patent Application for Combination Treatment of Cocaine Addiction - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea - The Manila Times

Mar 10, 2025
pulisher
Mar 06, 2025

SciSparc Extends $2 Million Loan to Support Automax?s Growth Following Automax?s Entry into Direct Import of JAC Electric Vehicles - Marketscreener.com

Mar 06, 2025
pulisher
Mar 05, 2025

SciSparc Ltd. Agrees to Sell MitoCareX to N2OFF - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

SciSparc signs definitive agreement to sell MitoCareX to N2OFF - TipRanks

Mar 05, 2025
pulisher
Mar 03, 2025

SciSparc to sell MitoCareX to N2Off for $700,000 - MSN

Mar 03, 2025
pulisher
Mar 03, 2025

SciSparc divests MitoCareX stake for $700,000 and stock swa By Investing.com - Investing.com South Africa

Mar 03, 2025

Finanzdaten der Scisparc Ltd-Aktie (SPRC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):